Telemonitoring of Hypertensive Patients With Chronic Kidney Disease

Launched by UNIVERSITY OF ALBERTA · Sep 18, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at how well a system of home blood pressure monitoring works for patients in Northern Alberta who have both high blood pressure (hypertension) and chronic kidney disease (CKD). The study aims to compare two approaches: one group will receive regular home blood pressure checks along with support from a case manager who will help adjust their medications, while the other group will just use home monitoring and share their results with their usual healthcare providers. The main focus is to see how much blood pressure changes after 12 months in both groups and to understand how well the home monitoring system is accepted and its cost-effectiveness.

To participate, individuals must be at least 18 years old, live in the Peace River region, have a diagnosis of CKD, and be managing hypertension with medication. Participants will need to have a smartphone and access to the internet, as they’ll be using a device to measure their blood pressure multiple times a day. Throughout the study, they can expect to have regular monitoring and possible adjustments in their medications to achieve better blood pressure control. It's important to note that the study has a few exclusions, such as individuals with severe kidney disease, heart failure, or other serious health conditions. This research aims to improve health outcomes for people living in remote areas who are at higher risk for complications from these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age equal to and more than 18 years with documented diagnosis of established CKD (not on dialysis with eGFR \< 60 mL/min/1.73m2 and/or proteinuria \> 1 g/day)
• • Remote dwelling patients in the Peace River region of Alberta, Canada
• • Patients known with hypertension (physician diagnosed / self reported and currently taking antihypertensive medications)
• • Owning a smartphone (iOS or Android) with access to wireless internet connection.
• • Proficiency in English language (both verbal and written); and ability and willingness to provide informed consent for participation.
• • Ability and willingness to use the HBPT device (≥ 80% recordings sent in the training period)
• Exclusion Criteria:
• • Patients with hypertensive urgency or emergency identified during the training period (immediate consultation will be initiated with the patient's PCP or with a hypertension specialist)
• • Patients with stage 5 CKD (eGFR ≤ 15 ml/min/1.73m2) or patients receiving kidney replacement therapy
• • Heart failure with reduced ejection fraction
• • Presence of any terminal illness (life expectancy \< 1 year)
• • Participation in any ongoing clinical drug trial
• • Pregnancy, lactation / breastfeeding
• • Planning to relocate out of the Peace River region or residence in an area without mobile phone coverage.